Skin Cancer News and Research RSS Feed - Skin Cancer News and Research

Skin cancer is the most common type of cancer in the U.S. It occurs in more than a million people each year, including many older people. There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Of the three, melanoma is the most serious. Skin cancer occurs when abnormal cells form and multiply in an uncontrolled way in the epidermis, or abnormal cells from the epidermis invade the dermis of the skin. Basal cell carcinoma, squamous cell carcinoma, and melanoma are skin cancers that are named for the epidermal cells from which they develop.
AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. [More]
Study evaluates impact of myPath Melanoma diagnostic test

Study evaluates impact of myPath Melanoma diagnostic test

Myriad Genetics, Inc. today presented results from a pivotal clinical utility study of the Myriad myPath- Melanoma test at the 2014 College of American Pathologists (CAP) annual meeting in Chicago, Ill. [More]
Genetic mutation caused by ultraviolet light is likely driving force behind human skin cancers

Genetic mutation caused by ultraviolet light is likely driving force behind human skin cancers

A genetic mutation caused by ultraviolet light is likely the driving force behind millions of human skin cancers, according to researchers at the Stanford University School of Medicine. [More]
Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin). [More]
Keytruda drug gets FDA approval for treatment of advanced melanoma

Keytruda drug gets FDA approval for treatment of advanced melanoma

The U.S. Food and Drug Administration today approved a new immunotherapy drug to treat advanced melanoma, signaling a paradigm shift in the way the deadly skin cancer is treated. [More]
New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New actinic keratoses data presented at the 15th World Congress of Cancers of the Skin

New data from the international FIELD Study Repeat presented today at the 15th World Congress of Cancers of the Skin (WCCS) in Edinburgh, Scotland, demonstrate initial treatment with Picato® (ingenol mebutate gel) 0.015% is efficacious in treating actinic keratoses (AK) and, when followed by a repeat cycle for persistent and newly emerging AKs, this efficacy is further increased.1 The data also confirm two treatment cycles of Picato® are well tolerated by patients.2 [More]
Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals provides update on clinical trial program for lead immunotherapy products

Ascend Biopharmaceuticals, a Melbourne-based immunotherapy company, has released an update on the clinical trial pipeline for its lead immunotherapy products treating basal cell carcinoma (BCC) and breast cancer. [More]
Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen seeks EMA approval for marketing talimogene laherparepvec

Amgen today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the centralized procedure for talimogene laherparepvec seeking approval for the treatment of adults with melanoma that is regionally or distantly metastatic. [More]
Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

Men who are not well educated about prostate cancer face decisional conflict, finds UCLA study

They say knowledge is power, and a new UCLA study has shown this is definitely the case when it comes to men making the best decisions about how to treat their prostate cancer. [More]
Majority of states not measuring up on legislative solutions that fight cancer, shows report

Majority of states not measuring up on legislative solutions that fight cancer, shows report

A majority of states are not measuring up on legislative solutions that prevent and fight cancer, according to a new report released today by the American Cancer Society Cancer Action Network (ACS CAN). [More]
Scientists study about rare type of skin cancer, acral melanomas

Scientists study about rare type of skin cancer, acral melanomas

Acral melanomas, the rare type of skin cancer that caused musician Bob Marley's death, are genetically distinct from other types of skin cancer. [More]
Study identifies protein that appears to play key role in protecting people infected with tuberculosis

Study identifies protein that appears to play key role in protecting people infected with tuberculosis

UCLA-led study has identified a protein that appears to play a key role in protecting people infected with Mycobacterium tuberculosis — the bacterium that causes tuberculosis — from developing the active form of the disease. [More]
Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine. [More]
Experts provide advice on safe fun in the sun

Experts provide advice on safe fun in the sun

While everybody needs some sun exposure to produce vitamin D (not to mention fun) sunburn and excessive ultra violet (UV) light exposure can not only cause damage to your skin, but sometimes lead to cancer. Michael Marchetti, M.D., of the Emergency Department at Bayshore Community Hospital, and Kevin Roma, M.D. of Riverview Medical Center's Emergency Department share their advice on safe fun in the sun. [More]
Research report on the global non-melanoma skin cancer market

Research report on the global non-melanoma skin cancer market

Reportlinker.com announces that a new market research report is available in its catalogue: Global Non-melanoma Skin Cancer Market 2014-2018 [More]
Topical sunscreens are still the safe option for sun protection

Topical sunscreens are still the safe option for sun protection

From lotions to sprays to sticks, consumers already have a myriad of options to choose from when selecting a sunscreen. [More]
Cancer cells that break away from tumors may prefer to settle into soft bed

Cancer cells that break away from tumors may prefer to settle into soft bed

Cancer cells that break away from tumors to go looking for a new home may prefer to settle into a soft bed, according to new findings from researchers at the University of Illinois. [More]
Study: Nervous system and stress affect inflammatory skin conditions

Study: Nervous system and stress affect inflammatory skin conditions

Anyone who's had a pimple form right before an important event may wonder if stress caused the break out. [More]
Hand-held photoacoustic microscopy may change the way doctors treat, diagnose melanoma

Hand-held photoacoustic microscopy may change the way doctors treat, diagnose melanoma

A new hand-held device that uses lasers and sound waves may change the way doctors treat and diagnose melanoma, according to a team of researchers from Washington University in St. Louis. [More]
New probe can be used in 3 unique ways to detect cancer

New probe can be used in 3 unique ways to detect cancer

As thousands of vacationers hit the beach this summer, many of them will expose their unprotected bare limbs to direct UV sunlight, potentially putting them at risk of skin cancer later in life. [More]